Extracorporeal Cardiac Shock Wave Therapy (CSWT) for Treatment of Coronary Artery Disease in China
Keywords:
extracorporeal cardiac shock wave therapy, myocardial infarction, ventricular remodeling, angio genesis
Abstract
Coronary artery disease (CAD) is a leading cause of mortality worldwide. Common therapies in the treatment of CAD are invasive, insufficient and pose additional risks in patients with advanced refractory CAD. Cardiac shock wave therapy (CSWT) is a safe and effective noninvasive intervention in the management of patients with refractory CAD. In this article, we briefly outline our work in animals and humans, and discuss the advantages and perspectives of CSWT in China.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
References
Takahiro Nishida, Hiroaki Shimokawa, Keiji Oi, Hideki Tatewaki, Toyokazu Uwatoku, Kohtaro Abe, Yasuharu Matsumoto, Noriyoshi Kajihara, Masataka Eto, Takehisa Matsuda, Hisataka Yasui, Akira Takeshita, Kenji Sunagawa (2004) Extracorporeal Cardiac Shock Wave Therapy Markedly Ameliorates Ischemia-Induced Myocardial Dysfunction in Pigs in Vivo. 110(19), 3055-3061.
T Uwatoku, K Ito, A Kohtaro, K Oi, T Hizume, K Sunagawa, H Shimokawa (2007) Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs. 18, 397-404.
Yoshihiro Fukumoto, Akira Ito, Toyokazu Uwatoku, Tetsuya Matoba, Takuya Kishi, Haruki Tanaka, Akira Takeshita, Kenji Sunagawa, Hiroaki Shimokawa (2006) Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. 17(1), 63-70.
H Shimokawa, K Ito, Y Fukumoto, S Yasuda (2008) Extracorporeal cardiac shock wave therapy for ischemic heart disease. 17, 449-455.
A Khattab, B Brodersen, D Schuermann-Kuchenbrandt, H Beurich, R Tölg, V Geist, T Schäfer, G Richardt (2007) Extracorporeal cardiac shock wave therapy: first experience in the everyday practice for treatment of chronic refractory angina pectoris. 121, 84-85.
C Prinz, O Lindner, T Bitter, D Hering, W Burchert, D Horstkotte, L Faber (2009) Extracorporeal cardiac shock wave therapy ameliorates clinical symptoms and improves regional myocardial blood flow in a patient with severe coronary artery disease and refractory angina. 2009, 639594.
A Gutersohn, G Caspari, R Erbel (2000) Upregulation of Vascular Endothelial Growth Factor m-RNA in Human Umbilical Vascular Endothelial Cells Via Shock Waves. 2(S1), 42-42.
Kenta Ito, Yoshihiro Fukumoto, Hiroaki Shimokawa (2009) Extracorporeal Shock Wave Therapy as a New and Non-invasive Angiogenic Strategy. 219(1), 1-9.
Yoku Kikuchi, Kenta Ito, Yoshitaka Ito, Takashi Shiroto, Ryuji Tsuburaya, Kentaro Aizawa, Kiyotaka Hao, Yoshihiro Fukumoto, Jun Takahashi, Morihiko Takeda, Masaharu Nakayama, Satoshi Yasuda, Shinichi Kuriyama, Ichiro Tsuji, Hiroaki Shimokawa (2010) Double-Blind and Placebo-Controlled Study of the Effectiveness and Safety of Extracorporeal Cardiac Shock Wave Therapy for Severe Angina Pectoris. 74(3), 589-591.
Y Vasyuk, A Hadzegova, E Shkolnik (2007) Extracorporeal cardiac shock wave therapy: first experience in the everyday practice for treatment of chronic refractory angina pectoris. 16, 84-85.
Hiroaki Shimokawa, Kenta Ito, Yoshihiro Fukumoto, Satoshi Yasuda (2008) Extracorporeal cardiac shock wave therapy for ischemic heart disease. 17(6), 449-455.
H Cai, Y Wang, L Li (2010) Changes in the number of endothelial progenitor cells from peripheral blood in patients with coronary atherosclerotic heart disease before and after extracorporeal cardiac shock wave therapy. 14(49), 9249-9252.
H Cai, Y Wang, L Li, L Zhao, X Yang, J Xiao, J Cao, X Yang, C Yang, T Guo (2010) e0388 Effect of endothelial progenitor cells from peripheral blood in patients with coronary heart disease before and after extracorporeal cardiac shock wave therapy. 96(Suppl 3), 120-A120.
S Tao, T Guo, Y Wang (2010) Effects of low-energy extracorporeal shock wave on myocardial matrix metalloproteinase system and ischemic myocardial capillary density after acute myocardial infarction. 14(37), 6979-6984.
S Tao, T Guo, Y Wang (2012) Effect of extracorporeal cardiac shock wave therapy on left Engineering. 16(24), 4453-4458.
S Sun, T Guo (2010) Effects of Extracorporeal Cardiac Shock Wave Therapy on Expression of Endothelial Nitric Oxide Synthase and Basic Fibroblast Growth Factor in Swine with Acute Myocardial Infarction. 26(9), 769-772.
S Sun, T Guo (2010) Cardioprotective role of myocardial endothelial nitric oxide synthase and serum nitric oxide induced by hexarelin in rats with myocardial infarction-induced heart failure. 13(15), 1660-1663.
Shuai Sun, Tao Guo (2010) e0221 Effects of extracorporeal cardiac shock wave therapy on expression of endothelial nitric oxide synthase and basic fibroblast growth factor in swine with acute myocardial infarction. 96(Suppl 3), A71.2-A71.
Yu Wang, Tao Guo, Hong‐yan Cai, Tie‐kun Ma, Si‐ming Tao, Shuai Sun, Ming‐qing Chen, Yun Gu, Jia‐hua Pang, Jian‐ming Xiao, Xi‐yun Yang, Chao Yang (2010) Cardiac Shock Wave Therapy Reduces Angina and Improves Myocardial Function in Patients With Refractory Coronary Artery Disease. 33(11), 693-699.
Yu Wang, Tao Guo, Tie-Kun Ma, Hong-Yan Cai, Si-Ming Tao, Yun-Zhu Peng, Ping Yang, Ming-Qing Chen, Yun Gu (2010) A modified regimen of extracorporeal cardiac shock wave therapy for treatment of coronary artery disease. 10(1), 711-715.
P Yang, T Guo, W Wang (2012) Randomized and double-blind controlled clinical trial of extra corporeal cardiac shock wave therapy for coronary heart disease.
Y Peng, T Guo, P Yang (2012) Effects of extracorporeal cardiac shock wave therapy in patients with ischemic heart failure. 40(2), 141-146.
Published
2014-10-17
Issue
Section
License
Copyright (c) 2014 Authors and Global Journals Private Limited

This work is licensed under a Creative Commons Attribution 4.0 International License.